- cross-posted to:
- world@lemmy.world
- cross-posted to:
- world@lemmy.world
cross-posted from: https://lemm.ee/post/64669906
https://archive.is/MLDhz
Proposed EU reforms would cut a minimum eight-year window companies have to exclusively sell new drugs they produce before cheaper generic competitors can enter the market.
Pharmaceutical companies have fiercely opposed any reduction in the minimum eight-year window, where they have “protection” over their research and data from clinical trials.
Minister for Enterprise Peter Burke said the Government now supports the position pushed by the pharmaceutical industry that there should be no change. “We are prepared to accept eight years,” he said in Brussels on Thursday.
You must log in or register to comment.